Tivic Reports Q1 2025 Financial Results and Business Updates
15 May 2025 //
BUSINESSWIRE
Tivic partners Scorpius BioManufacturing for FDA submission
14 May 2025 //
BUSINESSWIRE
Tivic Expands VNS Intellectual Property Portfolio
13 May 2025 //
BUSINESSWIRE
Tivic Health to Report Q1 2025 Results on May 15th via Call
09 May 2025 //
BUSINESSWIRE
Tivic Health Reports White House Briefing and FDA Meetings Spark
22 Apr 2025 //
BUSINESSWIRE
Tivic Health Extends Worldwide License for TLR5 Agonist Entolimod
15 Apr 2025 //
BUSINESSWIRE
Tivic Health Systems complies with NASDAQ bid price rule
10 Apr 2025 //
BUSINESSWIRE
Tivic Reports 2024 Financial Results and Strategy for Growth
21 Mar 2025 //
BUSINESSWIRE
Tivic Health to Report 2024 Financial Results on March 21st via Call
13 Mar 2025 //
BUSINESSWIRE
Tivic Health Systems Announces Reverse Stock Split
05 Mar 2025 //
BUSINESSWIRE
Tivic Health Acquires Worldwide Rights To Ph 3 TLR5 Agonist
12 Feb 2025 //
BUSINESSWIRE
Tivic Health Accelerates VNS Commercial Strategy Development
17 Sep 2024 //
BUSINESSWIRE
Tivic Partners With InStep Health to Access Over 2,500 Healthcare Providers
26 Sep 2023 //
BUSINESSWIRE
Tivic Health Systems Regains Compliance With Nasdaq Listing Requirements
20 Sep 2023 //
BUSINESSWIRE
Tivic Health Agreement with AmerisourceBergen for Retail Pharmacy Customers
28 Aug 2023 //
BUSINESSWIRE
Letter from the CEO of Tivic Health, Jennifer Ernst.
28 Jul 2023 //
BUSINESSWIRE
Tivic Health To Report First Quarter 2023 Financial Results
11 May 2023 //
BUSINESSWIRE
Tivic Health Expands Study of Post-Operative Pain in Nasal & Sinus Surgeries
19 Apr 2023 //
BUSINESSWIRE
Tivic Announces Recertification of ISO 13485 Quality Management System
23 Feb 2023 //
BUSINESSWIRE
Tivic Health Systems Announces Pricing of Public Offering
08 Feb 2023 //
BUSINESSWIRE
Tivic Health’s CEO, Jennifer Ernst, to Speak at Bioelectronic Medicine Summit
06 Oct 2022 //
BUSINESSWIRE
Tivic Health Collaborates With Leading Hospital to Extend Bioelectronic Platform
19 Jan 2022 //
BUSINESSWIRE